ACRS vs MSFT: Which Stock is Better?
Side-by-side comparison of Aclaris Therapeutics Inc and Microsoft Corp in 2026
ACRS
Aclaris Therapeutics Inc
$4.43
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | ACRS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $283.86M | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | -0.2% | 14.9% | MSFT |
| Gross Margin | -275.7% | 68.8% | MSFT |
Analyze ACRS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRS or MSFT a better investment?
Comparing ACRS and MSFT: Aclaris Therapeutics Inc has a market cap of $283.86M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRS and MSFT?
ACRS (Aclaris Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRS or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRS or MSFT?
MSFT has higher revenue growth at 14.9% vs -0.2% for ACRS.
Which company is more profitable: ACRS or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to -275.7% for ACRS.
Which is the larger company: ACRS or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $283.86M for ACRS.
Should I buy ACRS or MSFT in 2026?
Both ACRS and MSFT have investment merit. ACRS trades at $4.43 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRS and MSFT stock?
Key differences: Market Cap ($283.86M vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (-0.2% vs 14.9%), Gross Margin (-275.7% vs 68.8%).